{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:43Z","timestamp":1792794283051,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116982","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:08:23Z","timestamp":1780736903000},"page":"116982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Local delivery of GPC3-CAR T cells in a thermosensitive hydrogel enhances antitumor efficacy in hepatocellular carcinoma"],"prefix":"10.1016","volume":"185","author":[{"given":"Yu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongYi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.intimp.2026.116982_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jha2.338","article-title":"Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice","volume":"3","author":"Sengsayadeth","year":"2021","journal-title":"eJHaem"},{"issue":"3","key":"10.1016\/j.intimp.2026.116982_bb0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116982_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11912-023-01380-x","article-title":"CAR-T therapies in solid Tumors: opportunities and challenges","volume":"25","author":"Guzman","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2026.116982_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41551-018-0235-9","article-title":"Programming CAR-T cells to kill cancer","volume":"2","author":"Labanieh","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"10","key":"10.1016\/j.intimp.2026.116982_bb0025","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s43018-020-00119-y","article-title":"\"GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision,\" (in eng)","volume":"1","author":"Wang","year":"2020","journal-title":"Nat. Cancer"},{"issue":"51","key":"10.1016\/j.intimp.2026.116982_bb0030","doi-asserted-by":"crossref","first-page":"56712","DOI":"10.1021\/acsami.0c15239","article-title":"\u201cinjectable porous microchips with oxygen reservoirs and an immune-niche enhance the efficacy of CAR T cell therapy in solid Tumors,\u201d (in eng)","volume":"12","author":"Luo","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.intimp.2026.116982_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121872","article-title":"\u201cInjectable and photocurable CAR-T cell formulation enhances the anti-tumor activity to melanoma in mice,\u201d (in eng)","volume":"291","author":"Zhou","year":"2022","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.intimp.2026.116982_bb0040","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1021\/acs.chemrev.0c01177","article-title":"Translational applications of hydrogels","volume":"121","author":"Correa","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.intimp.2026.116982_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.747398","article-title":"Mechanobiological strategies to enhance stem cell functionality for regenerative medicine and tissue engineering","volume":"9","author":"Shafiq","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.116982_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2014.10.024","article-title":"Delivery systems for the treatment of degenerated intervertebral discs","volume":"84","author":"Blanquer","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"36","key":"10.1016\/j.intimp.2026.116982_bb0055","doi-asserted-by":"crossref","first-page":"7616","DOI":"10.1016\/j.biomaterials.2005.05.036","article-title":"In vitro characterization of chitosan\u2013gelatin scaffolds for tissue engineering","volume":"26","author":"Huang","year":"2005","journal-title":"Biomaterials"},{"issue":"5317","key":"10.1016\/j.intimp.2026.116982_bb0060","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1126\/science.276.5317.1425","article-title":"\u201cgeometric control of cell life and death,\u201d (in eng)","volume":"276","author":"Chen","year":"1997","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.intimp.2026.116982_bb0065","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2026.116982_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116262","article-title":"Suppressing phosphoinositide-specific phospholipases Cgamma1 promotes mineralization of osteoarthritic subchondral bone osteoblasts via increasing autophagy, thereby ameliorating articular cartilage degeneration","volume":"154","author":"Wang","year":"2022","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.intimp.2026.116982_bb0075","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116982_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biomaterials.2015.10.021","article-title":"Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies","volume":"75","author":"Monette","year":"2016","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2026.116982_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jim.2009.07.010","article-title":"MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis","volume":"348","author":"Soman","year":"2009","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.intimp.2026.116982_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2006.09.005","article-title":"Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET","volume":"116","author":"Ho","year":"2006","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.intimp.2026.116982_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nbt.3104","article-title":"Biopolymer implants enhance the efficacy of adoptive T-cell therapy","volume":"33","author":"Stephan","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116982_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/cancers9070092","article-title":"Regional delivery of chimeric antigen receptor (CAR) T-cells for Cancer therapy","volume":"9","author":"Sridhar","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.116982_bb0105","doi-asserted-by":"crossref","unstructured":"A. K. Grosskopf et al., \"Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors,\" (in eng), Sci. Adv., vol. 8, no. 14, p. eabn8264, Apr 8 2022, doi:https:\/\/doi.org\/10.1126\/sciadv.abn8264.","DOI":"10.1126\/sciadv.abn8264"},{"issue":"5","key":"10.1016\/j.intimp.2026.116982_bb0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11912-023-01380-x","article-title":"CAR-T therapies in solid Tumors: opportunities and challenges","volume":"25","author":"Guzman","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2026.116982_bb0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejca.2010.10.024","article-title":"Glypican-3: a new target for cancer immunotherapy","volume":"47","author":"Ho","year":"2011","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2026.116982_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.febslet.2013.10.002","article-title":"Glypican-3 antibodies: a new therapeutic target for liver cancer","volume":"588","author":"Feng","year":"2014","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.intimp.2026.116982_bb0125","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.ymthe.2019.04.020","article-title":"Combined antitumor effects of sorafenib and GPC3-CAR T cells in mouse models of hepatocellular carcinoma","volume":"27","author":"Wu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2026.116982_bb0130","doi-asserted-by":"crossref","unstructured":"D. Shi et al., \"Chimeric antigen receptor-Glypican-3 T-cell therapy for advanced hepatocellular carcinoma results of phase I trials,\" Clin. Cancer Res., vol. 26, no. 15, pp. 3979\u20133989, 2020\/8\/1 2020, doi:https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3259.","DOI":"10.1158\/1078-0432.CCR-19-3259"},{"issue":"8","key":"10.1016\/j.intimp.2026.116982_bb0135","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1053\/j.gastro.2020.02.011","article-title":"Persistent polyfunctional chimeric antigen receptor T cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in mice","volume":"158","author":"Li","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.intimp.2026.116982_bb0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.116982_bb0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11060-019-03311-y","article-title":"Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function","volume":"145","author":"Caruso","year":"2019","journal-title":"J. Neurooncol"},{"issue":"7","key":"10.1016\/j.intimp.2026.116982_bb0150","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/bm500502n","article-title":"Thermoreversible poly(ethylene glycol)-g-chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy","volume":"15","author":"Tsao","year":"2014","journal-title":"Biomacromolecules"},{"issue":"7","key":"10.1016\/j.intimp.2026.116982_bb0155","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/icb.2015.14","article-title":"Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma","volume":"93","author":"Highton","year":"2015","journal-title":"Immunol. Cell Biol."},{"issue":"29","key":"10.1016\/j.intimp.2026.116982_bb0160","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1016\/j.biomaterials.2011.03.065","article-title":"Thermosensitive chitosan-gelatin-glycerol phosphate hydrogel as a controlled release system of ferulic acid for nucleus pulposus regeneration","volume":"32","author":"Cheng","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116982_bb0165","doi-asserted-by":"crossref","unstructured":"D. T. Uslu U, Assenmacher CA, Scholler J, Young RM, Tchou J, June CH., \"chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma,\" Scinence Advances, vol. 9, no. 2, p. eade2526, 2023, doi:https:\/\/doi.org\/10.1126\/sciadv.ade2526.","DOI":"10.1126\/sciadv.ade2526"},{"issue":"10","key":"10.1016\/j.intimp.2026.116982_bb0170","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s43018-020-00119-y","article-title":"GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision","volume":"1","author":"Wang","year":"2020","journal-title":"Nature Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:31:01Z","timestamp":1784230261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926008283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S1567576926008283"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116982","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local delivery of GPC3-CAR T cells in a thermosensitive hydrogel enhances antitumor efficacy in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116982"}}